SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-19-007352
Filing Date
2019-06-07
Accepted
2019-06-07 16:38:25
Documents
2
Period of Report
2019-06-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 9366
2 venesspoa.txt EX-24 3280
  Complete submission text file 0001179110-19-007352.txt   13988
Mailing Address 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SIDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Issuer) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O ACCELERON PHARMA INC. 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Veness Adam M (Reporting) CIK: 0001778623 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36065 | Film No.: 19886177